Boston Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
16,357
-2,842
-15% -$321K ﹤0.01% 592
2025
Q4
$2.41M Sell
19,199
-1,676
-8% -$214K ﹤0.01% 549
2025
Q3
$2.8M Sell
20,875
-9,217
-31% -$1.21M ﹤0.01% 524
2025
Q2
$4.09M Sell
30,092
-3,107,794
-99% -$410M ﹤0.01% 462
2025
Q1
$416M Sell
3,137,886
-541,794
-15% -$69M 0.5% 58
2024
Q4
$417M Sell
3,679,680
-53,184
-1% -$6.15M 0.51% 60
2024
Q3
$426M Sell
3,732,864
-57,823
-2% -$6.34M 0.5% 68
2024
Q2
$394M Sell
3,790,687
-18,361
-0.5% -$1.95M 0.49% 65
2024
Q1
$432M Buy
3,809,048
+36,378
+1% +$4.17M 0.51% 65
2023
Q4
$416M Buy
3,772,670
+3,742,912
+12,578% +$374M 0.55% 54
2023
Q3
$2.88M Buy
29,758
+25,707
+635% +$2.7M ﹤0.01% 456
2023
Q2
$442K Buy
4,051
+24
+0.6% +$2.56K ﹤0.01% 638
2023
Q1
$408K Sell
4,027
-22
-0.5% -$2.32K ﹤0.01% 622
2022
Q4
$445K Sell
4,049
-13,085
-76% -$1.35M ﹤0.01% 609
2022
Q3
$1.66M Sell
17,134
-3,144
-16% -$335K ﹤0.01% 466
2022
Q2
$2.2M Sell
20,278
-1,777
-8% -$202K ﹤0.01% 433
2022
Q1
$2.61M Sell
22,055
-8,707
-28% -$1.08M ﹤0.01% 446
2021
Q4
$4.33M Sell
30,762
-7,169
-19% -$918K 0.01% 390
2021
Q3
$4.48M Sell
37,931
-14,331
-27% -$1.76M 0.01% 388
2021
Q2
$6.06M Sell
52,262
-45,076
-46% -$5.25M 0.01% 377
2021
Q1
$11.7M Sell
97,338
-14,010
-13% -$1.66M 0.02% 357
2020
Q4
$12.2M Sell
111,348
-1,036,806
-90% -$113M 0.02% 333
2020
Q3
$125M Sell
1,148,154
-70,587
-6% -$7.16M 0.23% 139
2020
Q2
$111M Sell
1,218,741
-628,705
-34% -$56.8M 0.2% 150
2020
Q1
$146M Buy
1,847,446
+107,762
+6% +$8.99M 0.29% 104
2019
Q4
$151M Sell
1,739,684
-172,229
-9% -$14.4M 0.2% 144
2019
Q3
$160M Sell
1,911,913
-103,440
-5% -$8.79M 0.22% 134
2019
Q2
$169M Sell
2,015,353
-111,798
-5% -$8.8M 0.22% 135
2019
Q1
$170M Sell
2,127,151
-168,845
-7% -$12.6M 0.23% 136
2018
Q4
$166M Sell
2,295,996
-291,628
-11% -$20.5M 0.24% 121
2018
Q3
$190M Buy
2,587,624
+45,473
+2% +$2.99M 0.22% 129
2018
Q2
$155M Buy
2,542,151
+213,732
+9% +$13M 0.19% 146
2018
Q1
$140M Buy
2,328,419
+5,018
+0.2% +$302K 0.17% 158
2017
Q4
$133M Sell
2,323,401
-7,494,862
-76% -$415M 0.16% 158
2017
Q3
$524M Sell
9,818,263
-698,239
-7% -$35M 0.65% 37
2017
Q2
$511M Buy
10,516,502
+2,304,467
+28% +$104M 0.65% 41
2017
Q1
$365M Buy
8,212,035
+8,069,557
+5,664% +$349M 0.47% 71
2016
Q4
$5.47M Buy
+142,478
New +$5.65M 0.01% 485
2013
Q3
Sell
-86,857
Closed -$3.03M 689
2013
Q2
$3.03M Buy
+86,857
New +$3.19M 0.01% 553

Other funds holding ABT

Boston Partners's ABT Position: Q1 2026 in Review

Boston Partners reduced its Abbott (ABT) stake by 15% in Q1 2026, selling an estimated $321K and leaving 16,357 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #592.

Boston Partners first reported a position in ABT in Q2 2013 and has held it in 39 quarters since. The position peaked at $524M in Q3 2017. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Boston Partners held 16,357 shares of Abbott worth $1.68M as of Q1 2026.
  • Boston Partners sold 2,842 Abbott shares in Q1 2026, an estimated $321K.
  • Abbott made up ﹤0.01% of Boston Partners's portfolio in Q1 2026, its #592 holding.
  • Boston Partners first reported a position in Abbott in Q2 2013 and has held it in 39 quarters since.
  • Boston Partners's Abbott position peaked at $524M in Q3 2017.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.